RETRACTED: Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway

• Xiaozhong Liao,
• Xiaozhong Liao,
• Xiaozhong Liao,
• Ying Gao,
• Jiahui Liu,
• Jiahui Liu,
• Lanting Tao,
• Dongmei Wang,
• Dan Xie,
• Suilin Mo

Affiliations

Xiaozhong Liao

Department of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

Xiaozhong Liao

The State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

Xiaozhong Liao

Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

Ying Gao

Department of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

Jiahui Liu

Department of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

Jiahui Liu

Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

Lanting Tao

Department of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

Dongmei Wang

School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China

Dan Xie

The State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

Suilin Mo

Department of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China